Cite
Ngo TB, Karkanitsa M, Adusei KM, et al. SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States. medRxiv. 2021;doi: 10.1101/2021.08.10.21261849.
Ngo, T. B., Karkanitsa, M., Adusei, K. M., Graham, L. A., Ricotta, E. E., Darrah, J. R., Blomberg, R. D., Spathies, J., Pauly, K. J., Klumpp-Thomas, C., Travers, J., Mehalko, J., Drew, M., Hall, M. D., Memoli, M. J., Esposito, D., Kozar, R. A., Griggs, C., Cunningham, K. W., Schulman, C. I., Crandall, M., Neavyn, M., Dorfman, J. D., Lai, J. T., Whitehill, J. M., Babu, K. M., Mohr, N. M., Van Heukelom, J., Fell, J. C., Rooke, W., Kalish, H., Thomas, F. D., & Sadtler, K. (2021). SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.08.10.21261849
Ngo, Tran B, et al. "SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.08.10.21261849
Ngo TB, Karkanitsa M, Adusei KM, Graham LA, Ricotta EE, Darrah JR, Blomberg RD, Spathies J, Pauly KJ, Klumpp-Thomas C, Travers J, Mehalko J, Drew M, Hall MD, Memoli MJ, Esposito D, Kozar RA, Griggs C, Cunningham KW, Schulman CI, Crandall M, Neavyn M, Dorfman JD, Lai JT, Whitehill JM, Babu KM, Mohr NM, Van Heukelom J, Fell JC, Rooke W, Kalish H, Thomas FD, Sadtler K. SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States. medRxiv. 2021 Aug 11; doi: 10.1101/2021.08.10.21261849. PMID: 34401892; PMCID: PMC8366813.
Copy
Download .nbib